SEC Form 4 · accession 0001140361-17-040543

Loxo Oncology, Inc. · LOXO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joshua H. Bilenker

Officer — President & CEO · Director

Period of report

Oct 30, 2017

Accepted (ET)

Nov 1, 2017 · 5:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001581720

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 30, 2017	M	7,500	$1.184	A	196,207	D
Common Stock^F2,F3	Oct 30, 2017	S	5,690	$86.8752	D	190,517	D
Common Stock^F2,F4	Oct 30, 2017	S	998	$87.7386	D	189,519	D
Common Stock^F2,F5	Oct 30, 2017	S	812	$88.7737	D	188,707	D
Common Stock	Oct 31, 2017	M	7,500	$1.184	A	196,207	D
Common Stock^F2,F6	Oct 31, 2017	S	2,961	$86.1788	D	193,246	D
Common Stock^F2,F7	Oct 31, 2017	S	4,339	$86.6545	D	188,907	D
Common Stock^F2,F8	Oct 31, 2017	S	200	$87.665	D	188,707	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F9	$1.184	Oct 30, 2017	M	7,500	D	—	Nov 14, 2023	Common Stock	7,500	127,190	D
Employee Stock Option (right to buy)^F9	$1.184	Oct 31, 2017	M	7,500	D	—	Nov 14, 2023	Common Stock	7,500	119,690	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2Represents the aggregate of sales effected on the same day at different prices.
F3Represents the weighted average sales price per share. The shares sold at prices ranging from $86.26 to $87.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4Represents the weighted average sales price per share. The shares sold at prices ranging from $87.28 to $88.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5Represents the weighted average sales price per share. The shares sold at prices ranging from $88.34 to $89.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6Represents the weighted average sales price per share. The shares sold at prices ranging from $85.46 to $86.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F7Represents the weighted average sales price per share. The shares sold at prices ranging from $86.46 to $87.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F8Represents the weighted average sales price per share. The shares sold at prices ranging from $87.59 to $87.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F9The stock option is immediately exercisable in full, and vests as to 25% of the shares subject to the option on the one-year anniversary of the vesting commencement date, and thereafter as to 1/48th of the shares in equal monthly installments.